Combined Laser-surgical Technology of RRD Treatment

  • days left to enroll
  • participants needed
  • sponsor
    The S.N. Fyodorov Eye Microsurgery State Institution
Updated on 24 January 2021


Purpose: to assess the efficacy and safety of combined laser-surgical technology of RRD treatment


The study takes place in the S.N. Fyodorov "Eye Microsurgery" Federal State Institution located in Moscow, Russian Federation.

The study will include 50 patients with rhegmatogenous retinal detachment due to a horseshoe-tear. In addition to the standard ophthalmological examination, all patients will undergo wide-field optical coherence tomography to determine the extension and localization of the vitreoretinal traction zone. The obtained data will be used to planning the 1st step of laser-surgical treatment. All patients will undergo a combined laser-surgical technology, which includes 3 steps: 1) Nd-YAG laser excision of the vitreoretinal traction zone 2) pneumatic retinopexy (10% C3F8) 3) barrier laser photocoagulation around retinal break after retinal attachment.

The patients are going to be followed up for at least 1 year, the main outcome measures are postoperative primary and final anatomic outcome, BCVA and complications.

Condition Rhegmatogenous Retinal Detachment
Treatment Combined laser-surgical technology of RRD treatment
Clinical Study IdentifierNCT04403750
SponsorThe S.N. Fyodorov Eye Microsurgery State Institution
Last Modified on24 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 60 yrs?
Gender: Male or Female
Do you have Rhegmatogenous Retinal Detachment?
Do you have any of these conditions: Do you have Rhegmatogenous Retinal Detachment??
Rhegmatogenous retinal detachment extending from the 9-o'clock to the 3-o'clock meridians
Superior retinal break from 9 o'clock to 3 o'clock
Single retinal break not greater than 1 clock hours in size
Physically and mentally co-operated in post-operative head positioning
No (or minimal) proliferative vitreoretinopathy
None or mild vitreous hemorrhage

Exclusion Criteria

Severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas); OR
Ocular media opacities
Previous ocular surgeries
Age <18 years
Previous retinal detachment (index eye)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note